Andrea B Apolo (Andrea Apolo)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 26

Top Topics

Locally Advanced

Squamous Cell Carcinoma

Neoadjuvant Chemotherapy

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Nature communications

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Andrea B Apolo, Daniel M Girardi, Scot A Niglio, Rosa Nadal Rios, Andre R Kydd, Nicholas Simon, Lisa Ley, Lisa M Cordes, Elias B A Chandran, Seth M Steinberg, Sunmin Lee, Min-Jung Lee, Shraddha Rastogi, Nahoko Sato, Liang Cao, A Rouf Banday, Salah Boudjadi, Maria J Merino, Antoun Toubaji, Dilara Akbulut, Bernadette Redd, Hadi Bagheri, Rene Costello, Sandeep Gurram, Piyush K Agarwal, Heather J Chalfin, Vladimir Valera, Howard Streicher, John Joseph Wright, Elad Sharon, William Douglas Figg, Howard L Parnes, James L Gulley, Biren Saraiya, Sumanta Kumar Pal, David I Quinn, Mark N Stein, Primo N Lara, Donald P Bottaro, Amir Mortazavi
Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Chandra Sekhar Amara, Karthik Reddy Kami Reddy, Yang Yuntao, Yuen San Chan, Danthasinghe Waduge Badrajee Piyarathna, Lacey Elizabeth Dobrolecki, David J H Shih, Zhongcheng Shi, Jun Xu, Shixia Huang, Matthew J Ellis, Andrea B Apolo, Leomar Y Ballester, Jianjun Gao, Donna E Hansel, Yair Lotan, H Courtney Hodges, Seth P Lerner, Chad J Creighton, Arun Sreekumar, Wenjin Jim Zheng, Pavlos Msaouel, Shyam M Kavuri, Nagireddy Putluri
The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer. Nature communications 15 (1) (2024)
Elias B A Chandran, Giovanni Maria Iannantuono, Saad O Atiq, Dilara Akbulut, Ninet Sinaii, Nicholas I Simon, Abdul Rouf Banday, Salah Boudjadi, Sandeep Gurram, Amin H Nassar, Jonathan E Rosenberg, Gisela Butera, Min Yuen Teo, Guru P Sonpavde, Jonathan A Coleman, Andrea B Apolo
Mismatch repair deficiency and microsatellite instability in urothelial carcinoma: a systematic review and meta-analysis. BMJ oncology 3 (1) (2024)
Andrea B Apolo, Daniel M Girardi, Scot A Niglio, Rosa Nadal Rios, Andre R Kydd, Nicholas Simon, Lisa Ley, Lisa M Cordes, Elias B A Chandran, Seth M Steinberg, Sunmin Lee, Min-Jung Lee, Shraddha Rastogi, Nahoko Sato, Liang Cao, A Rouf Banday, Salah Boudjadi, Maria J Merino, Antoun Toubaji, Dilara Akbulut, Bernadette Redd, Hadi Bagheri, Rene Costello, Sandeep Gurram, Piyush K Agarwal, Heather J Chalfin, Vladimir Valera, Howard Streicher, John Joseph Wright, Elad Sharon, William Douglas Figg, Howard L Parnes, James L Gulley, Biren Saraiya, Sumanta Kumar Pal, David I Quinn, Mark N Stein, Primo N Lara, Donald P Bottaro, Amir Mortazavi
Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Andrea B Apolo, Daniel M Girardi, Scot A Niglio, Rosa Nadal Rios, Andre R Kydd, Nicholas Simon, Lisa Ley, Lisa M Cordes, Elias B A Chandran, Seth M Steinberg, Sunmin Lee, Min-Jung Lee, Shraddha Rastogi, Nahoko Sato, Liang Cao, A Rouf Banday, Salah Boudjadi, Maria J Merino, Antoun Toubaji, Dilara Akbulut, Bernadette Redd, Hadi Bagheri, Rene Costello, Sandeep Gurram, Piyush K Agarwal, Heather J Chalfin, Vladimir Valera, Howard Streicher, John Joseph Wright, Elad Sharon, William Douglas Figg, Howard L Parnes, James L Gulley, Biren Saraiya, Sumanta Kumar Pal, David I Quinn, Mark N Stein, Primo N Lara, Donald P Bottaro, Amir Mortazavi
Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Chandra Sekhar Amara, Karthik Reddy Kami Reddy, Yang Yuntao, Yuen San Chan, Danthasinghe Waduge Badrajee Piyarathna, Lacey Elizabeth Dobrolecki, David J H Shih, Zhongcheng Shi, Jun Xu, Shixia Huang, Matthew J Ellis, Andrea B Apolo, Leomar Y Ballester, Jianjun Gao, Donna E Hansel, Yair Lotan, H Courtney Hodges, Seth P Lerner, Chad J Creighton, Arun Sreekumar, Wenjin Jim Zheng, Pavlos Msaouel, Shyam M Kavuri, Nagireddy Putluri
The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer. Nature communications 15 (1) (2024)
Elias B A Chandran, Giovanni Maria Iannantuono, Saad O Atiq, Dilara Akbulut, Ninet Sinaii, Nicholas I Simon, Abdul Rouf Banday, Salah Boudjadi, Sandeep Gurram, Amin H Nassar, Jonathan E Rosenberg, Gisela Butera, Min Yuen Teo, Guru P Sonpavde, Jonathan A Coleman, Andrea B Apolo
Mismatch repair deficiency and microsatellite instability in urothelial carcinoma: a systematic review and meta-analysis. BMJ oncology 3 (1) (2024)
Andrea B Apolo, Karla V Ballman, Guru Sonpavde, Stephanie Berg, William Y Kim, Rahul Parikh, Min Yuen Teo, Randy F Sweis, Daniel M Geynisman, Petros Grivas, Gurkamal Chatta, Zachery Roger Reichert, Joseph W Kim, Mehmet Asim Bilen, Bradley McGregor, Parminder Singh, Abhishek Tripathi, Suzanne Cole, Nicholas Simon, Scot Niglio, Lisa Ley, Lisa Cordes, Sandy Srinivas, Jiaoti Huang, Meagan Odegaard, Colleen Watt, Daniel Petrylak, Jeannie Hoffman-Censits, Yujia Wen, Olwen Hahn, Cecilia Mitchell, Alan Tan, Howard Streicher, Elad Sharon, Helen Moon, Michael Woods, Susan Halabi, Gabriela Perez Burbano, Michael J Morris, Jonathan E Rosenberg
Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma. The New England journal of medicine (2024)
Elias B A Chandran, Giovanni Maria Iannantuono, Saad O Atiq, Dilara Akbulut, Ninet Sinaii, Nicholas I Simon, Abdul Rouf Banday, Salah Boudjadi, Sandeep Gurram, Amin H Nassar, Jonathan E Rosenberg, Gisela Butera, Min Yuen Teo, Guru P Sonpavde, Jonathan A Coleman, Andrea B Apolo
Mismatch repair deficiency and microsatellite instability in urothelial carcinoma: a systematic review and meta-analysis. BMJ oncology 3 (1) (2024)
Chandra Sekhar Amara, Karthik Reddy Kami Reddy, Yang Yuntao, Yuen San Chan, Danthasinghe Waduge Badrajee Piyarathna, Lacey Elizabeth Dobrolecki, David J H Shih, Zhongcheng Shi, Jun Xu, Shixia Huang, Matthew J Ellis, Andrea B Apolo, Leomar Y Ballester, Jianjun Gao, Donna E Hansel, Yair Lotan, H Courtney Hodges, Seth P Lerner, Chad J Creighton, Arun Sreekumar, Wenjin Jim Zheng, Pavlos Msaouel, Shyam M Kavuri, Nagireddy Putluri
The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer. Nature communications 15 (1) (2024)
Andrea B Apolo, Daniel M Girardi, Scot A Niglio, Rosa Nadal Rios, Andre R Kydd, Nicholas Simon, Lisa Ley, Lisa M Cordes, Elias B A Chandran, Seth M Steinberg, Sunmin Lee, Min-Jung Lee, Shraddha Rastogi, Nahoko Sato, Liang Cao, A Rouf Banday, Salah Boudjadi, Maria J Merino, Antoun Toubaji, Dilara Akbulut, Bernadette Redd, Hadi Bagheri, Rene Costello, Sandeep Gurram, Piyush K Agarwal, Heather J Chalfin, Vladimir Valera, Howard Streicher, John Joseph Wright, Elad Sharon, William Douglas Figg, Howard L Parnes, James L Gulley, Biren Saraiya, Sumanta Kumar Pal, David I Quinn, Mark N Stein, Primo N Lara, Donald P Bottaro, Amir Mortazavi
Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Elias B A Chandran, Giovanni Maria Iannantuono, Saad O Atiq, Dilara Akbulut, Ninet Sinaii, Nicholas I Simon, Abdul Rouf Banday, Salah Boudjadi, Sandeep Gurram, Amin H Nassar, Jonathan E Rosenberg, Gisela Butera, Min Yuen Teo, Guru P Sonpavde, Jonathan A Coleman, Andrea B Apolo
Mismatch repair deficiency and microsatellite instability in urothelial carcinoma: a systematic review and meta-analysis. BMJ oncology 3 (1) (2024)
Jonathan A Coleman, Wesley Yip, Nathan C Wong, Daniel D Sjoberg, Bernard H Bochner, Guido Dalbagni, S Machele Donat, Harry W Herr, Eugene K Cha, Timothy F Donahue, Eugene J Pietzak, Abraham Ari Hakimi, Kwanghee Kim, Hikmat A Al-Ahmadie, H Alberto Vargas, Ricardo G Alvim, Soleen Ghafoor, Nicole E Benfante, Anoop M Meraney, Steven J Shichman, Jeffrey M Kamradt, Suresh G Nair, Angelo A Baccala, Paul Palyca, Bradley W Lash, Muhammad A Rizvi, Scott K Swanson, Antonio F Muina, Andrea B Apolo, Gopakumar V Iyer, Jonathan E Rosenberg, Min Yuen Teo, Dean F Bajorin
Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Jonathan A Coleman, Wesley Yip, Nathan C Wong, Daniel D Sjoberg, Bernard H Bochner, Guido Dalbagni, S Machele Donat, Harry W Herr, Eugene K Cha, Timothy F Donahue, Eugene J Pietzak, Abraham Ari Hakimi, Kwanghee Kim, Hikmat A Al-Ahmadie, H Alberto Vargas, Ricardo G Alvim, Soleen Ghafoor, Nicole E Benfante, Anoop M Meraney, Steven J Shichman, Jeffrey M Kamradt, Suresh G Nair, Angelo A Baccala, Paul Palyca, Bradley W Lash, Muhammad A Rizvi, Scott K Swanson, Antonio F Muina, Andrea B Apolo, Gopakumar V Iyer, Jonathan E Rosenberg, Min Yuen Teo, Dean F Bajorin
Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Jonathan A Coleman, Wesley Yip, Nathan C Wong, Daniel D Sjoberg, Bernard H Bochner, Guido Dalbagni, S Machele Donat, Harry W Herr, Eugene K Cha, Timothy F Donahue, Eugene J Pietzak, Abraham Ari Hakimi, Kwanghee Kim, Hikmat A Al-Ahmadie, H Alberto Vargas, Ricardo G Alvim, Soleen Ghafoor, Nicole E Benfante, Anoop M Meraney, Steven J Shichman, Jeffrey M Kamradt, Suresh G Nair, Angelo A Baccala, Paul Palyca, Bradley W Lash, Muhammad A Rizvi, Scott K Swanson, Antonio F Muina, Andrea B Apolo, Gopakumar V Iyer, Jonathan E Rosenberg, Min Yuen Teo, Dean F Bajorin
Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Ashish M Kamat, Andrea B Apolo, Marek Babjuk, Trinity J Bivalacqua, Peter C Black, Roger Buckley, Matthew T Campbell, Eva Compérat, Jason Alexander Efstathiou, Petros D Grivas, Shilpa Gupta, Neil J Kurtz, Donald Lamm, Seth P Lerner, Roger Li, David J McConkey, Joan Palou Redorta, Thomas Powles, Sarah P Psutka, Neal D Shore, Gary D Steinberg, Richard Sylvester, J Alfred Witjes, Matthew D Galsky
Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Society for Immunotherapy of Cancer and the International Bladder Cancer Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Jonathan A Coleman, Wesley Yip, Nathan C Wong, Daniel D Sjoberg, Bernard H Bochner, Guido Dalbagni, S Machele Donat, Harry W Herr, Eugene K Cha, Timothy F Donahue, Eugene J Pietzak, Abraham Ari Hakimi, Kwanghee Kim, Hikmat A Al-Ahmadie, H Alberto Vargas, Ricardo G Alvim, Soleen Ghafoor, Nicole E Benfante, Anoop M Meraney, Steven J Shichman, Jeffrey M Kamradt, Suresh G Nair, Angelo A Baccala, Paul Palyca, Bradley W Lash, Muhammad A Rizvi, Scott K Swanson, Antonio F Muina, Andrea B Apolo, Gopakumar V Iyer, Jonathan E Rosenberg, Min Yuen Teo, Dean F Bajorin
Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Juliane Manitz, Sandra P D' Angelo, Andrea B Apolo, S Peter Eggleton, Marcis Bajars, Oliver Bohnsack, James L Gulley
Comparison of tumor assessments using RECIST 1.1 and irRECIST, and association with overall survival. Journal for immunotherapy of cancer 10 (2) (2022)
Fotis Nikolos, Kazukuni Hayashi, Xen Ping Hoi, Mark Ellie Alonzo, Qianxing Mo, Armine Kasabyan, Hideki Furuya, Jane Trepel, Dolores Di Vizio, Jlenia Guarnerio, Dan Theodorescu, Charles J Rosser, Andrea B Apolo, Matthew Galsky, Keith Syson Chan
Cell death-induced immunogenicity enhances chemoimmunotherapeutic response by converting immune-excluded into T-cell inflamed bladder tumors. Nature communications 13 (1) (2022)
Daniel M Girardi, Scot A Niglio, Amir Mortazavi, Rosa Nadal Rios, Primo Lara, Sumanta K Pal, Biren Saraiya, Lisa Cordes, Lisa Ley, Olena Sierra Ortiz, Jacqueline Cadena, Carlos Diaz, Hadi Bagheri, Bernadette Redd, Seth M Steinberg, Rene Costello, Keith S Chan, Min-Jung Lee, Min-Jung Lee, Yunkai Yu, Sandeep Gurram, Heather J Chalfin, Vladimir Valera, William Douglas Figg, Maria J Merino, Antoun Toubaji, Howard Streicher, John J Wright, Elad Sharon, Howard L Parnes, Yang-Min Ning, Donald P Bottaro, Liang Cao, Jane B Trepel, Andrea B Apolo
Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (7) (2022)
Karen Kelly, Juliane Manitz, Manish R Patel, Sandra P D' Angelo, Andrea B Apolo, Arun Rajan, Vijay Kasturi, Isabell Speit, Marcis Bajars, John Warth, James L Gulley
Efficacy and immune-related adverse event associations in avelumab-treated patients. Journal for immunotherapy of cancer 8 (2) (2021)
Elaine Chang, Andrea B Apolo, Rick Bangs, Stephanie Chisolm, Vinay A Duddalwar, Jason A Efstathiou, Kirsten B Goldberg, Donna E Hansel, Ashish M Kamat, Paul G Kluetz, Seth P Lerner, Elizabeth Plimack, Tatiana Prowell, Harpreet Singh, Daniel Suzman, Evan Y Yu, Hui Zhang, Julia A Beaver, Richard Pazdur, Chana Weinstock, Matthew D Galsky
Refining neoadjuvant therapy clinical trial design for muscle-invasive bladder cancer before cystectomy: a joint US Food and Drug Administration and Bladder Cancer Advocacy Network workshop. Nature reviews. Urology (2021)
Andrea B Apolo, John A Ellerton, Jeffrey R Infante, Manish Agrawal, Michael S Gordon, Raid Aljumaily, Theodore Gourdin, Luc Dirix, Keun-Wook Lee, Matthew H Taylor, Patrick Schöffski, Ding Wang, Alain Ravaud, Juliane Manitz, Gregory Pennock, Mary Ruisi, James L Gulley, Manish R Patel
Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis. Journal for immunotherapy of cancer 8 (2) (2021)
Andrea B Apolo, Rosa Nadal Rios, Daniel M Girardi, Scot A Niglio, Lisa Ley, Lisa M Cordes, Seth M Steinberg, Olena Sierra Ortiz, Jacqueline Cadena, Carlos Diaz, Marissa Mallek, Nicole N Davarpanah, Rene Costello, Jane B Trepel, Min-Jung Lee, Maria J Merino, Mohammad Hadi Bagheri, Paul Monk, William D Figg, James L Gulley, Piyush K Agarwal, Vladimir Valera, Heather J Chalfin, Jennifer C Jones, Howard Streicher, John J Wright, Yangmin M Ning, Howard L Parnes, William L Dahut, Donald P Bottaro, Primo N Lara, Biren Saraiya, Sumanta Kumar Pal, Mark N Stein, Amir Mortazavi
Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 38 (31) (2020)
Vid Leko, Lucas A McDuffie, Zhili Zheng, Jared J Gartner, Todd D Prickett, Andrea B Apolo, Piyush K Agarwal, Steven A Rosenberg, Yong-Chen William Lu
Identification of Neoantigen-Reactive Tumor-Infiltrating Lymphocytes in Primary Bladder Cancer. Journal of immunology (Baltimore, Md. : 1950) 202 (12) (2019)
Carl W Noble, Sapna S Gangaputra, Ian A Thompson, Amy Yuan, Andrea B Apolo, Jung-Min Lee, George N Papaliodis, Shilpa Kodati, Rachel Bishop, M Teresa Magone, Lucia Sobrin, H Nida Sen
Ocular Adverse Events following Use of Immune Checkpoint Inhibitors for Metastatic Malignancies. Ocular immunology and inflammation 28 (6) (2019)